Literature DB >> 8150064

Tetanus in Switzerland 1980-1989.

P L Zuber1, A Schierz, G Aréstegui, R Steffen.   

Abstract

Tetanus cases that occurred in Switzerland between 1980 and 1989 have been reviewed with the help of three data surveillance systems: a) morbidity data from the Federal Office of Public Health (FOPH), b) mortality data from the Swiss Federal Statistical Office (SFSO), and c) data from the Association of Swiss Hospitals and Clinics (VESKA), completed by a written enquiry to clinics which did not (or only partly) participate in the VESKA system during the study period. For every case, a questionnaire was sent to the clinic to verify the diagnosis and to obtain additional information on the circumstances of occurrence. Ninety-one cases were identified. This corresponds to a yearly incidence of 1.93 per million population between 1980-84 and 0.88 for the 1985-89 period (p < 0.01). Eighty-one percent of the cases were older than 50 years of age and women were significantly more frequently affected than men. None of the cases identified had a documented primary immunization series. Data available at the FOPH and SFSO level have been compared to data obtained through the VESKA system using the Chandra Sekhar and Deming method. It is estimated that 134 tetanus cases (95% CI: 91-197) have occurred in Switzerland between 1980 and 1989, together with 28 deaths (95% CI: 27-31). Based on these estimates, FOPH appears to detect only 6-13% of tetanus cases occurring in Switzerland. By contrast, SFSO had fairly consistent data for 81-100% of tetanus associated deaths. The low rate of tetanus reported by physicians necessitates a sustained effort to increase the understanding of epidemiological surveillance by Swiss practitioners.

Entities:  

Mesh:

Year:  1993        PMID: 8150064     DOI: 10.1007/bf00211435

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  11 in total

1.  Tetanus--United States, 1987 and 1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-01-26       Impact factor: 17.586

2.  Case definitions for public health surveillance.

Authors:  M Wharton; T L Chorba; R L Vogt; D L Morse; J W Buehler
Journal:  MMWR Recomm Rep       Date:  1990-10-19

3.  Update on adult immunization. Recommendations of the Immunization Practices Advisory Committee (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1991-11-15

4.  Congenital rubella syndrome in the United States, 1970-1985. On the verge of elimination.

Authors:  S L Cochi; L E Edmonds; K Dyer; W L Greaves; J S Marks; E Z Rovira; S R Preblud; W A Orenstein
Journal:  Am J Epidemiol       Date:  1989-02       Impact factor: 4.897

Review 5.  Immunization policies and vaccine coverage among adults. The risk for missed opportunities.

Authors:  W W Williams; M A Hickson; M A Kane; A P Kendal; J S Spika; A R Hinman
Journal:  Ann Intern Med       Date:  1988-04       Impact factor: 25.391

6.  Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984.

Authors:  R W Sutter; S L Cochi; E W Brink; B I Sirotkin
Journal:  Am J Epidemiol       Date:  1990-01       Impact factor: 4.897

7.  [The epidemiologic trend in tetanus in Lombardy].

Authors:  A Buratta; V CArreri; C Porro Dé Somenzi
Journal:  Boll Ist Sieroter Milan       Date:  1980-11-30

Review 8.  Botulism and tetanus: selected epidemiologic and microbiologic aspects.

Authors:  V R Dowell
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

9.  Epidemiology of tetanus in Denmark 1920-1982.

Authors:  O Simonsen; A V Bloch; I Heron
Journal:  Scand J Infect Dis       Date:  1987

10.  Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.

Authors:  O Simonsen; K Kjeldsen; I Heron
Journal:  Lancet       Date:  1984-12-01       Impact factor: 79.321

View more
  3 in total

Review 1.  Factors affecting the immunogenicity and potency of tetanus toxoid: implications for the elimination of neonatal and non-neonatal tetanus as public health problems.

Authors:  V Dietz; A Galazka; F van Loon; S Cochi
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

2.  The Swiss Paediatric Surveillance Unit (SPSU).

Authors:  H Zimmermann; D Desgrandchamps; G Schubiger
Journal:  Soz Praventivmed       Date:  1995

Review 3.  Immunodeficiency of aging.

Authors:  E A Burns; J S Goodwin
Journal:  Drugs Aging       Date:  1997-11       Impact factor: 4.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.